Eating more mushrooms could help prevent Alzheimer's by lowering amyloid build-up, reducing inflammation, and supporting nerve growth in the aging brain

Mushrooms are being linked to lower Alzheimer's risk through compounds that may reduce amyloid plaque formation, calm neuroinflammation, and support neurogenesis and overall brain resilience. The focus is nutritional and biomedical rather than recreational, centering on how regular mushroom consumption could influence cognitive decline over time. Evidence commonly cited in this area includes antioxidant and anti-inflammatory effects, modulation of immune signaling, and bioactive molecules such as ergothioneine, hericenones, and erinacines found in certain species. Lion's mane is especially notable because it has been studied for potential nerve growth factor support and memory-related benefits in aging populations. The broader implication is that edible and medicinal mushrooms may become part of preventive brain-health strategies, though stronger human trials are still needed to clarify dose, species-specific effects, and how much protection they can realistically provide against Alzheimer's disease.